vs
Side-by-side financial comparison of Hims & Hers Health, Inc. (HIMS) and LifeMD, Inc. (LFMD). Click either name above to swap in a different company.
Hims & Hers Health, Inc. is the larger business by last-quarter revenue ($617.8M vs $7.1M, roughly 87.3× LifeMD, Inc.). LifeMD, Inc. runs the higher net margin — 282.0% vs 3.3%, a 278.6% gap on every dollar of revenue. On growth, Hims & Hers Health, Inc. posted the faster year-over-year revenue change (28.4% vs 5.0%). Hims & Hers Health, Inc. produced more free cash flow last quarter ($-2.5M vs $-3.4M). Over the past eight quarters, Hims & Hers Health, Inc.'s revenue compounded faster (49.0% CAGR vs -60.0%).
Hims & Hers Health, Inc. is an American telehealth company established in 2017. The company provides prescription medications, over-the-counter medications, and personal care products.
SBI Life Insurance Company Limited is an Indian life insurance company. It was started as a joint venture between State Bank of India (SBI) and French financial institution BNP Paribas Cardif.
HIMS vs LFMD — Head-to-Head
Income Statement — Q4 2025 vs Q4 2025
| Metric | | |
|---|---|---|
| Revenue | $617.8M | $7.1M |
| Net Profit | $20.6M | $20.0M |
| Gross Margin | 71.9% | 40.2% |
| Operating Margin | 1.5% | -87.9% |
| Net Margin | 3.3% | 282.0% |
| Revenue YoY | 28.4% | 5.0% |
| Net Profit YoY | -20.8% | 742.5% |
| EPS (diluted) | $0.08 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $617.8M | $7.1M | ||
| Q3 25 | $599.0M | $60.2M | ||
| Q2 25 | $544.8M | $62.7M | ||
| Q1 25 | $586.0M | $64.1M | ||
| Q4 24 | $481.1M | $6.7M | ||
| Q3 24 | $401.6M | $53.3M | ||
| Q2 24 | $315.6M | $50.7M | ||
| Q1 24 | $278.2M | $44.1M |
| Q4 25 | $20.6M | $20.0M | ||
| Q3 25 | $15.8M | $-3.8M | ||
| Q2 25 | $42.5M | $-1.6M | ||
| Q1 25 | $49.5M | $-183.8K | ||
| Q4 24 | $26.0M | $-3.1M | ||
| Q3 24 | $75.6M | $-4.7M | ||
| Q2 24 | $13.3M | $-6.9M | ||
| Q1 24 | $11.1M | $-6.8M |
| Q4 25 | 71.9% | 40.2% | ||
| Q3 25 | 73.8% | 87.7% | ||
| Q2 25 | 76.4% | 88.1% | ||
| Q1 25 | 73.5% | 86.5% | ||
| Q4 24 | 76.8% | -0.8% | ||
| Q3 24 | 79.2% | 90.6% | ||
| Q2 24 | 81.3% | 90.1% | ||
| Q1 24 | 82.4% | 89.6% |
| Q4 25 | 1.5% | -87.9% | ||
| Q3 25 | 2.0% | -3.3% | ||
| Q2 25 | 4.9% | -0.7% | ||
| Q1 25 | 9.9% | 1.5% | ||
| Q4 24 | 3.9% | -58.2% | ||
| Q3 24 | 5.6% | -7.5% | ||
| Q2 24 | 3.5% | -12.4% | ||
| Q1 24 | 3.6% | -14.0% |
| Q4 25 | 3.3% | 282.0% | ||
| Q3 25 | 2.6% | -6.3% | ||
| Q2 25 | 7.8% | -2.6% | ||
| Q1 25 | 8.4% | -0.3% | ||
| Q4 24 | 5.4% | -46.1% | ||
| Q3 24 | 18.8% | -8.7% | ||
| Q2 24 | 4.2% | -13.6% | ||
| Q1 24 | 4.0% | -15.3% |
| Q4 25 | $0.08 | — | ||
| Q3 25 | $0.06 | — | ||
| Q2 25 | $0.17 | $-0.05 | ||
| Q1 25 | $0.20 | $-0.02 | ||
| Q4 24 | $0.10 | — | ||
| Q3 24 | $0.32 | $-0.13 | ||
| Q2 24 | $0.06 | — | ||
| Q1 24 | $0.05 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $228.6M | — |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $540.9M | $23.2M |
| Total Assets | $2.2B | $70.4M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $228.6M | — | ||
| Q3 25 | $345.8M | — | ||
| Q2 25 | $1.1B | $36.2M | ||
| Q1 25 | $273.7M | $34.4M | ||
| Q4 24 | $220.6M | $35.0M | ||
| Q3 24 | $165.5M | $37.6M | ||
| Q2 24 | $129.3M | $35.7M | ||
| Q1 24 | $105.2M | $35.1M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | $15.9M | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $540.9M | $23.2M | ||
| Q3 25 | $581.0M | $1.3M | ||
| Q2 25 | $562.7M | $-1.8M | ||
| Q1 25 | $549.3M | $-2.3M | ||
| Q4 24 | $476.7M | $-9.1M | ||
| Q3 24 | $440.1M | $-7.7M | ||
| Q2 24 | $362.0M | $-4.2M | ||
| Q1 24 | $344.5M | $-845.3K |
| Q4 25 | $2.2B | $70.4M | ||
| Q3 25 | $2.2B | $66.0M | ||
| Q2 25 | $1.9B | $73.6M | ||
| Q1 25 | $891.7M | $73.6M | ||
| Q4 24 | $707.5M | $76.1M | ||
| Q3 24 | $602.3M | $72.6M | ||
| Q2 24 | $480.5M | $63.8M | ||
| Q1 24 | $448.1M | $61.5M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $61.3M | $-3.3M |
| Free Cash FlowOCF − Capex | $-2.5M | $-3.4M |
| FCF MarginFCF / Revenue | -0.4% | -48.5% |
| Capex IntensityCapex / Revenue | 10.3% | 2.2% |
| Cash ConversionOCF / Net Profit | 2.98× | -0.16× |
| TTM Free Cash FlowTrailing 4 quarters | $57.4M | $6.4M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $61.3M | $-3.3M | ||
| Q3 25 | $148.7M | $-147.1K | ||
| Q2 25 | $-19.1M | $8.6M | ||
| Q1 25 | $109.1M | $3.1M | ||
| Q4 24 | $86.4M | $1.1M | ||
| Q3 24 | $85.3M | $6.7M | ||
| Q2 24 | $53.6M | $4.5M | ||
| Q1 24 | $25.8M | $5.2M |
| Q4 25 | $-2.5M | $-3.4M | ||
| Q3 25 | $79.3M | $-944.4K | ||
| Q2 25 | $-69.5M | $7.8M | ||
| Q1 25 | $50.1M | $2.9M | ||
| Q4 24 | $59.5M | $875.4K | ||
| Q3 24 | $79.4M | $6.3M | ||
| Q2 24 | $47.6M | $3.9M | ||
| Q1 24 | $11.8M | $5.0M |
| Q4 25 | -0.4% | -48.5% | ||
| Q3 25 | 13.2% | -1.6% | ||
| Q2 25 | -12.8% | 12.5% | ||
| Q1 25 | 8.5% | 4.6% | ||
| Q4 24 | 12.4% | 13.0% | ||
| Q3 24 | 19.8% | 11.7% | ||
| Q2 24 | 15.1% | 7.7% | ||
| Q1 24 | 4.3% | 11.4% |
| Q4 25 | 10.3% | 2.2% | ||
| Q3 25 | 11.6% | 1.3% | ||
| Q2 25 | 9.3% | 1.3% | ||
| Q1 25 | 10.1% | 0.2% | ||
| Q4 24 | 5.6% | 2.9% | ||
| Q3 24 | 1.5% | 0.8% | ||
| Q2 24 | 1.9% | 1.3% | ||
| Q1 24 | 5.0% | 0.4% |
| Q4 25 | 2.98× | -0.16× | ||
| Q3 25 | 9.43× | — | ||
| Q2 25 | -0.45× | — | ||
| Q1 25 | 2.20× | — | ||
| Q4 24 | 3.32× | — | ||
| Q3 24 | 1.13× | — | ||
| Q2 24 | 4.03× | — | ||
| Q1 24 | 2.32× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
